EVASEP: A Noninterventional Study Describing the Perception of Neurologists, Patients, and Caregivers on Caregivers’ Role in the Support of Patients Suffering from Multiple Sclerosis Treated with Subcutaneous Interferon Beta 1a

Figure 6

Radar plot of the physical, psychological, affective, and professional impact of the treatment. Sixteen components of the physical, psychological, affective, and professional impact of the disease on the patient were assessed by the physician and the patient, while caregivers assessed the impact of the disease on their own life. For the latter, only 14 out of 16 components were investigated: the impacts of the disease on their autonomy and finances were not considered.